The DOI matches its Crossref record; 495 of the 496 references it cites were found in a registry or an index.
2019 Alzheimer’s disease facts and figures.
Abstract
This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality and morbidity, use and costs of care, and the overall impact on caregivers and society. The Special Report examines the use of brief cognitive assessments by primary care physicians as a tool for improving early detection of dementia. An estimated 5.8 million Americans have Alzheimer's dementia. By mid‐century, the number of people living with Alzheimer's dementia in the United States may grow to 13.8 million, fueled in large part by the aging baby boom generation. In 2017, official death certificates recorded 121,404 deaths from AD, making AD the sixth leading cause of death in the United States and the fifth leading cause of death among Americans age ≥65 years. Between 2000 and 2017, deaths resulting from stroke, heart disease, and prostate cancer decreased, whereas reported deaths from AD increased 145%. In 2018, more than 16 million family members and other unpaid caregivers provided an estimated 18.5 billion hours of care to people with Alzheimer's or other dementias. This care is valued at nearly $234 billion, but its costs extend to family caregivers' increased risk for emotional distress and negative mental and physical health outcomes. Average per‐person Medicare payments for services to beneficiaries age ≥65 years with Alzheimer's or other dementias are more than three times as great as payments for beneficiaries without these conditions. Total payments in 2019 for health care, long‐term care and hospice services for people age ≥65 years with dementia are estimated to be $290 billion. Early detection of Alzheimer's offers numerous medical, emotional and financial benefits—benefits that accrue to affected individuals and their families as well as to society at large. Alzheimer's Association surveys regarding brief cognitive assessments for detection of dementia found that while a large majority of seniors and primary care physicians say the assessments are important, only half of seniors have received an assessment, and only 16 percent of seniors receive regular cognitive assessments. Many educational opportunities exist to facilitate increased use of brief cognitive assessments in the primary care setting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“precise identification of FTD and AD, which are the two most common types of dementia in the younger-elderly population (Bang et al., 2015; Association, 2019), is of vital clinical significance in the diagnosis of dementias.”
From Deep Learning-Based Classification and Voxel-Based Visualization of Frontotemporal Dementia and Alzheimer's Disease (2021) · cites this paper as Association, 2019
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
International Statistical Classification of Diseases and Related Health Problems
(2010) · Springer eBooks · doi:10.1007/978-0-387-79948-3_3055 · Cited by 4,182
What is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Research works printed but not linked: 26
- Grossberg GT, 2010, The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: Recommendations of an expert consensus panel, Prim Care Companion J Clin Psychiatry, 12
- 2015, Cognitive Aging: Progress in Understanding and Opportunity for Action
- Sajeev G, Diabetes. The AlzRisk Database. Alzheimer Research Forum
- Steptoe A, 2005, Aging, Health, and Public Policy
- He W, 2016, International Population Reports, P95/16‐1, An Aging World: 2015
- 2006, Early‐Onset Dementia: A National Challenge, a Future Crisis
- Manly JJ, 2004, Critical perspectives on racial and ethnic differentials in health in late life, 95
- Prince MJ, 2015, World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence
- Ortman JM, 2014, An Aging Nation: The Older Population in the United States, Current Population Reports, P25‐1140
- Heron M, 2018, Deaths: Leading causes for 2016
- Kasper JD, 2014, Disability and Care Needs of Older Americans by Dementia Status: An Analysis of the 2011 National Health and Aging Trends Study
- Maslow K, 2012, Translating Innovation to Impact: Evidence‐Based Interventions to Support People with Alzheimer's Disease and their Caregiver at Home and in the Community
- Zarit SH, 2009, Aging families and caregiving, 131
- Whitlatch CJ, 2018, Meeting the informational, educational, and psychosocial support needs of persons living with dementia and their family caregivers, Gerontologist, 58, S58
- Khatutsky G, 2011, Understanding direct care workers: A snapshot of two of America's most important jobs: Certified nursing assistants and home health aides
- Stone R, 2012, Universal Coverage of Long‐Term Care in the United States: Can We Get There from Here?, 155
- Eldercare Workforce Alliance, 2012, Geriatrics Workforce Shortage: A Looming Crisis for our Families
- National Academies of Sciences, 2016, Engineering, and Medicine. Families Caring for an Aging America
- Eiken S, 2018, Medicaid Expenditures for Long‐Term Services and Supports in FY 2016. IAP Medicaid Innovation Accelerator Program
- Bynum J, 2009, Unpublished; provided under contract with the Alzheimer's Association
- Jacobson G, 2017, Income and Assets of Medicare Beneficiaries, 2016‐2035
- National Association of Insurance Commissioners and the Center for Insurance Policy and Research, 2016, The State of Long‐Term Care Insurance: The Market, Challenges and Future Innovations
- Reaves EL, 2015, Medicaid and Long‐Term Services and Supports: A Primer
- 10.1111/j.1525-1497.2005.0126.x · DOI
- Albert SM, 2010, The MetLife Study of working caregivers and employer health care costs
- Shriver M, 2010, The Shriver Report: A Woman's Nation Takes on Alzheimer's
Cited by
Sorted by citations
Items 901–1,000 of 1,019
Attention-Guided Deep Graph Neural Network for Longitudinal Alzheimer’s Disease Analysis
Ma, J., Zhu, X., Yang, D., Chen, J., & Guorong Wu, A. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-59728-3_38 · Cited by 19
LivingMoments: Bespoke Social Communication for People living with Dementia and their Relatives
Thoolen, M., Toso, F., Peek, S. T. M., Lü, Y., & Brankaert, R. (2022) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3491102.3517430 · Cited by 19
Bayraktar, Y., Işık, E., Işık, İ., Özyılmaz, A., Toprak, M., GÜLOĞLU, F. K., & Aydın, S. (2022) · Sustainability · doi:10.3390/su14137901 · Cited by 19
Wayfinding Strategies and Spatial Anxiety in Older Adults With and Without Alzheimer's Disease
Davis, R., & Veltkamp, A. (2019) · Research in Gerontological Nursing · doi:10.3928/19404921-20191022-03 · Cited by 18
Dementia Worry and Neuropsychological Performance in Healthy Older Adults
Caughie, C. A., Bean, P. S., Tiede, P., Cobb, J., McFarland, C. W., & Hall, S. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaa057 · Cited by 18
Lin, S., Schneider, C., Bristol, A. A., Clancy, M., Sprague, S. A., Aldridge, M. D., Cortes, T., Goldfeld, K. S., Kutner, J. S., Mitchell, S. L., et al. (2020) · The Gerontologist · doi:10.1093/geront/gnaa220 · Cited by 18
Faieta, J. M., Devos, H., Vaduvathiriyan, P., York, M. K., Erickson, K. I., Hirsch, M. A., Downer, B. G., van Wegen, E. E. H., Wong, D. C., Philippou, E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-020-01555-8 · Cited by 18
Leggett, A. N., Bugajski, B., Gitlin, L. N., & Kales, H. C. (2021) · Dementia · doi:10.1177/1471301220988233 · Cited by 18
Elverman, K. H., Paitel, E. R., Figueroa, C. M., McKindles, R. J., & Nielson, K. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201559 · Cited by 20
Aluminum in food and potential role on Alzheimer’s disease of aluminum
Alkaya, G. B., Demirci, C., & Şevik, H. (2021) · Turkish Journal of Engineering · doi:10.31127/tuje.846455 · Cited by 20
Bashir, D. J., Manzoor, S., Khan, I. A., Bashir, M., Agarwal, N. B., Rastogi, S., Arora, I., & Samim, M. (2022) · ACS Omega · doi:10.1021/acsomega.1c04459 · Cited by 18
Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
Villegas, C., Perez, R., Petiz, L. L., Glaser, T., Ulrich, H., & Paz, C. (2022) · IUBMB Life · doi:10.1002/iub.2613 · Cited by 18
Cardiorespiratory fitness and cognition in persons at risk for Alzheimer's disease
Vesperman, C. J., Wang, R., Schultz, S. A., Law, L. L., Dougherty, R. J., Ma, Y., Oh, J. M., Edwards, D. F., Gallagher, C. L., Chin, N. A., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12330 · Cited by 18
Honeys as Possible Sources of Cholinesterase Inhibitors
Szwajgier, D., Baranowska‐Wójcik, E., Winiarska‐Mieczan, A., & Gajowniczek-Ałasa, D. (2022) · Nutrients · doi:10.3390/nu14142969 · Cited by 18
Dhamodharan, J., Sekhar, G., & Muthuraman, A. (2022) · Molecules · doi:10.3390/molecules27165182 · Cited by 18
Huang, H., Liu, Q., Jiang, Y., Yang, Q., Zhu, X., & Li, Y. (2022) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2022.3202713 · Cited by 18
“A LZHEIMER’S disease (AD), a common form of demen-37 tia characterized by cognitive and intellectual deficits, which is serious enough to interfere with daily life and has not yet been effectively treated [1].”
BackgroundTomassen, J., den Braber, A., van der Landen, S. M., Konijnenberg, E., Teunissen, C. E., Vermunt, L., de Geus, E. J. C., Boomsma, D. I., Scheltens, P., Tijms, B. M., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12346 · Cited by 16
Multi-Modal Deep Learning Models for Alzheimer's Disease Prediction Using MRI and EHR
Prabhu, S. S., Berkebile, J. A., Rajagopalan, N., Yao, R., Shi, W., Giuste, F., Zhong, Y., Sun, J., & Wang, M. D. (2022) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe55377.2022.00044 · Cited by 18
“I. INTRODUCTION Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by a decline in cognitive functions with no validated disease-modifying treatment, identified as the sixth most burdensome disease in the United States [1].”
BackgroundCai, J., Hu, W., Ma, J., Si, A., Chen, S., Gong, L., Zhang, Y., Yan, H., Chen, F., & Initiative, A. D. N. (2023) · Brain Sciences · doi:10.3390/brainsci13111535 · Cited by 18
“According to the World Health Organization (WHO), approximately 50 million individuals are living with AD, and this number is expected to triple by 2050 [1].”
BackgroundAbosharaf, H. A., Elsonbaty, Y., Tousson, E., & Mohamed, T. M. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13356 · Cited by 19
Wang, X., Zhang, Y., Zhou, M., Liu, T., Qi, J., & Yang, P. (2023) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm58861.2023.10385644 · Cited by 18
Tu, L., Lv, X., Yuan, C., Chen, H., Yu, X., Wang, H., & Zhang, Q. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6072 · Cited by 21
Hussain, R., Khan, S., Khan, Y., Iqbal, T., Anwar, S., Aziz, T. A., & Alharbi, M. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138228 · Cited by 18
A Review of the Consequences of Gut Microbiota in Neurodegenerative Disorders and Aging
Menezes, A. A., & Shah, Z. A. (2024) · Brain Sciences · doi:10.3390/brainsci14121224 · Cited by 20
“In AD, the abnormal phosphorylation of the microtubule-associated protein tau in the dendrites and axons of cortical neurons leads to aggregation, resulting in A β deposition around or outside neurons and subsequent progressive synaptic failure [3,33,34].”
Meditation treatment of Alzheimer disease and mild cognitive impairment
Chen, Y., Zhang, J., Zhang, T., Cao, L., You, Y., Zhang, C., Liu, X., & Zhang, Q. (2020) · Medicine · doi:10.1097/md.0000000000019313 · Cited by 18
Extra-telomeric impact of telomeres: Emerging molecular connections in pluripotency or stemness
Vinayagamurthy, S., Ganguly, A., & Chowdhury, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.009710 · Cited by 22
Estolano-Cobián, A., Noriega-Iribe, E., Díaz-Rubio, L., Padrón, J. M., Brito-Perea, M. D. C., Cornejo‐Bravo, J. M., Chávez, D., Rivera, R. R., Melgoza, J. M. Q., Cruz-Reyes, J., et al. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02617-1 · Cited by 18
Lombardi, A., Amoroso, N., Diacono, D., Monaco, A., Logroscino, G., Blasi, R. D., Bellotti, R., & Tangaro, S. (2020) · Brain Sciences · doi:10.3390/brainsci10110879 · Cited by 18
Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia
Hannestad, J. O., Koborsi, K., Klutzaritz, V., Chao, W., Ray, R., Páez, A., Jackson, S., Lohr, S., Cummings, J. L., Kay, G. G., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12115 · Cited by 16
Ahmed, H. A., Soliman, H., & Elmogy, M. M. (2020) · International Conference on Data Analytics for Business and Industry (ICDABI) · doi:10.1109/icdabi51230.2020.9325640 · Cited by 19
Biocomputational Screening of Natural Compounds against Acetylcholinesterase
Ahmad, S. S., Khan, M. B., Ahmad, K., Lim, J. H., Shaikh, S., Lee, E. J., & Choi, I. (2021) · Molecules · doi:10.3390/molecules26092641 · Cited by 18
McEwen, S. C., Merrill, D. A., Bramen, J. E., Porter, V. R., Panos, S. E., Kaiser, S. A., Hodes, J. F., Ganapathi, A. S., Bell, L., Bookheimer, T., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12191 · Cited by 17
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
Ibáñez, L., Cruchaga, C., & Fernández, M. V. (2021) · Genes · doi:10.3390/genes12081247 · Cited by 20
Nanomaterials in Alzheimer’s disease treatment: a comprehensive review
Faiyaz, M., Ganayee, M. A., Akhtar, S., Krishnan, S., Flora, B., Dogra, D., Jha, N. K., Chellappan, D. K., Negi, P., Dua, K., et al. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4992 · Cited by 19
Vila‐Castelar, C., Muñoz, N., Papp, K. V., Amariglio, R. E., Baena, A. Y., Guzmán‐Vélez, E., Bocanegra, Y., Sanchez, J. S., Reiman, E. M., Johnson, K. A., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00671-w · Cited by 18
Shityakov, S., Hayashi, K., Störk, S., Scheper, V., Lenarz, T., & Förster, C. Y. (2021) · Biomolecules · doi:10.3390/biom11060900 · Cited by 18
Babulal, G. M. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117269 · Cited by 18
Chu, J., Benjenk, I., & Chen, J. (2021) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.09.020 · Cited by 17
Liu, J., Xu, Y., Liu, Y., Luo, H., Huang, W., & Yao, L. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3482001 · Cited by 19
“Although AD cannot be halted or reversed, the most efficacious approach to manage AD patients entails decelerating the progression of AD in its nascent stages [2].”
Tahiroğlu, V., Gören, K., & Bağlan, M. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-00958-4 · Cited by 17
The gut–brain axis in Alzheimer’s disease: how gut microbiota modulate microglial function
Wang, H., Yang, F., Gao, Z., Cheng, Z.-D., & Liang, X. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1704047 · Cited by 22
“As global populations age, the worldwide prevalence of dementia is projected to increase from 55 million in 2019 to 139 million by 2050 (Gaugler et al., 2019).”
Rural Caregivers: Identification of Informational Needs Through Telemedicine Questions
Bardach, S. H., Gibson, A., Parsons, K., Stauffer, A., & Jicha, G. A. (2020) · The Journal of Rural Health · doi:10.1111/jrh.12431 · Cited by 19
Characteristics and Outcomes of Dementia Patients Who Receive Inpatient Palliative Care Consultation
Sharda, N. K., Zietlow, K. E., Wong, S. P., Kuchibhatla, M. N., & Johnson, K. S. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16521 · Cited by 17
Lay Caregivers' Experiences With Caring for Persons With Dementia: A Phenomenological Study
Mayo, A. M., Siegle, K., Savell, E., Bullock, B., Preston, G. J., & Peavy, G. M. (2020) · Journal of Gerontological Nursing · doi:10.3928/00989134-20200527-02 · Cited by 17
OCTA in neurodegenerative optic neuropathies: emerging biomarkers at the eye–brain interface
Asanad, S., Mohammed, I. S. K., Sadun, A. A., & Saeedi, O. J. (2020) · Therapeutic Advances in Ophthalmology · doi:10.1177/2515841420950508 · Cited by 17
Mohammad, M., & Trounev, A. (2021) · Results in Physics · doi:10.1016/j.rinp.2020.103809 · Cited by 17
Nakhla, M. Z., Banuelos, D., Pagán, C. R., Olvera, A. G., & Razani, J. (2021) · Applied Neuropsychology Adult · doi:10.1080/23279095.2021.1893172 · Cited by 23
Yin, X., Xie, Q., Huang, L., Liu, L., Armstrong, E. G., Zhen, M., Ni, J., Shi, J., Tian, J., & Cheng, W. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210025 · Cited by 19
de Sousa, O. V., Mendes, J., & do Amaral, T. F. (2021) · Nutrition & Dietetics · doi:10.1111/1747-0080.12679 · Cited by 17
Global Perspectives on Brief Cognitive Assessments for Dementia Diagnosis1
Tsoy, E., Sideman, A. B., Piña‐Escudero, S. D., Pintado‐Caipa, M., Kanjanapong, S., Al‐Rousan, T., Mbakile‐Mahlanza, L., de Oliveira, M. O., Puebla, M. D. L. C., Zygouris, S., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201403 · Cited by 17
Gao, X., Li, S., Liu, X., Cong, C., Zhao, L., Liu, H., & Xu, L. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114379 · Cited by 18
Yan, D., Wang, S., Temkin‐Greener, H., & Cai, S. (2021) · Journal of Applied Gerontology · doi:10.1177/07334648211048187 · Cited by 17
Shojaie, M., Tabarestani, S., Cabrerizo, M., DeKosky, S. T., Vaillancourt, D. E., Loewenstein, D., Duara, R., & Adjouadi, M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210064 · Cited by 17
Cooper, R. A., & Pitts, M. J. (2021) · Journal of Social and Personal Relationships · doi:10.1177/02654075211058084 · Cited by 26
Clinician approaches to communicating a dementia diagnosis: An interview study
Wollney, E. N., Bylund, C. L., Bedenfield, N., Rosselli, M., Curiel, R. E., Kitaigorodsky, M., Levy, X., & Armstrong, M. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267161 · Cited by 17
Świetlik, D., Kusiak, A., & Ossowska, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084727 · Cited by 17
Gök, M., Madrer, N., Zorbaz, T., Bennett, E. R., Greenberg, D., Bennett, D. A., & Soreq, H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.941467 · Cited by 19
“Recent epidemiological studies indicate that worldwide, over 50 million individuals are affected by AD (Karlawish et al., 2017; Association, 2019) and 10 million by PD (Tysnes and Storstein, 2017; Vasili et al.”
BackgroundGiaquinto, F., Battista, P., & Angelelli, P. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220547 · Cited by 17
“[11].”
Acridine: A Scaffold for the Development of Drugs for Alzheimer's Disease
Sharma, A., & Piplani, P. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230203141543 · Cited by 17
Somin, S., Kulasiri, D., & Samarasinghe, S. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00344-2 · Cited by 18
Huertas‐Domingo, C., Losada‐Baltar, A., Romero‐Moreno, R., Gallego‐Alberto, L., & Márquez‐González, M. (2023) · Aging & Mental Health · doi:10.1080/13607863.2023.2195821 · Cited by 20
Flavonoids as Promising Multitarget Agents in Alzheimer’s Disease Therapy
Lima, E., Rauter, A. P., & Medeiros, J. (2023) · Applied Sciences · doi:10.3390/app13084651 · Cited by 17
Anwar, M. M. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01270-5 · Cited by 18
Women’s Brain Health: Midlife Ovarian Removal Affects Associative Memory
Brown, A., Gervais, N. J., Rieck, J. R., Almey, A., Gravelsins, L. L., Reuben, R. B., Karkaby, L., Rajah, M. N., Grady, C. L., & Einstein, G. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03424-6 · Cited by 19
Li, J., Wu, X., Tan, X., Wang, S., Qu, R., Wu, X., Chen, Z., Wang, Z., & Chen, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1257973 · Cited by 20
Hassan, N., Miah, A. S. M., Suzuki, T., & Shin, J. (2025) · IEEE Access · doi:10.1109/access.2025.3542458 · Cited by 20
Hashimie, J., Schultz, S. K., & Stewart, J. T. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.11.011 · Cited by 17
Informed consent, therapeutic misconception, and clinical trials for Alzheimer's disease
Wilkins, J. M., & Forester, B. P. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5262 · Cited by 17
Chang, Y., Lorenz, R. A., Phillips, M., Peng, H., & Szigeti, K. (2020) · Journal of Gerontological Nursing · doi:10.3928/00989134-20200527-01 · Cited by 17
Tatiparti, K., Sau, S., Rauf, M. A., & Iyer, A. K. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.025 · Cited by 16
Guo, X., Liu, Y., Morgan, D., & Zhao, L. (2020) · Aging and Disease · doi:10.14336/ad.2020.0201 · Cited by 16
Trumbore, C. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201025 · Cited by 17
Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia
Lee, J. Y., Marian, O. C., & Don, A. S. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08644-4 · Cited by 18
Gosztolya, G., Balogh, R., Imre, N., Egas-López, J. V., Hoffmann, I., Vincze, V., Tóth, L., Devanand, D. P., Pákáski, M., & Kálmán, J. (2021) · Computer Speech & Language · doi:10.1016/j.csl.2021.101215 · Cited by 17
Fausto, B. A., Azimipour, S., Charles, L., Yarborough, C. C., Grullon, K., Hokett, E., Duberstein, P. R., & Gluck, M. A. (2021) · Journal of Applied Gerontology · doi:10.1177/07334648211010580 · Cited by 17
Role of Mitochondrial Protein Import in Age-Related Neurodegenerative and Cardiovascular Diseases
Bogorodskiy, A. O., Okhrimenko, I. S., Burkatovskii, D., Jakobs, P., Maslov, I., Gordeliy, V., Dencher, N. A., Gensch, T., Voos, W., Altschmied, J., et al. (2021) · Cells · doi:10.3390/cells10123528 · Cited by 19
Gao, D., Wan, J., Zou, Y. F., Gong, Y., Dong, X., Xu, Z., Tang, J., Wei, G., & Zhang, Q. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp01754g · Cited by 17
Fabius, C. D., Ogarek, J. A., & Shireman, T. I. (2019) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-019-00621-9 · Cited by 17
Psychometric properties of the Insomnia Severity Index in a sample of family dementia caregivers
Jiménez-Gonzalo, L., Romero-Moreno, R., Pedroso-Chaparro, M. D. S., Gallego-Alberto, L., Barrera-Caballero, S., Olazarán, J., & Losada-Baltar, A. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.03.036 · Cited by 16
Bouldin, E. D., Taylor, C. A., Knapp, K. A., Miyawaki, C. E., Mercado, N. R., Wooten, K. G., & McGuire, L. C. (2020) · International Psychogeriatrics · doi:10.1017/s1041610220001635 · Cited by 16
The effect of resistance training on sleep in Chinese older adults: A randomized controlled trial
Li, Z., Li, J., Yu, G., Yu, F., Li, K., & Szanton, S. L. (2020) · Geriatric Nursing · doi:10.1016/j.gerinurse.2020.09.002 · Cited by 16
Liu, S., Zhou, T., Chen, D., Liu, R., Qin, H.-H., Min, Z.-L., Liu, G.-Q., & Cao, X. (2020) · Food & Function · doi:10.1039/d0fo02388d · Cited by 17
Quinuclidine-Based Carbamates as Potential CNS Active Compounds
Matošević, A., Kastelić, A. R., Mikelić, A., Zandona, A., Katalinić, M., Primožič, I., Bosak, A., & Hrenar, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030420 · Cited by 16
Skaaraas, G. H. E. S., Melbye, C., Puchades, M. A., Leung, D. S. Y., Jacobsen, Ø., Rao, S. B., Ottersen, O. P., Leergaard, T. B., & Torp, R. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210571 · Cited by 16
Development of Pervasive IoT Based Healthcare Monitoring System for Alzheimer Patients
Yadav, P., Kumar, P., Kishan, P., Raj, P., & raj, U. (2021) · Journal of Physics Conference Series · doi:10.1088/1742-6596/2007/1/012035 · Cited by 16
Multifunctional Small Molecules as Potential Anti-Alzheimer’s Disease Agents
Bargagna, B., Ciccone, L., Nencetti, S., Santos, M. A., Chaves, S., Camodeca, C., & Orlandini, E. (2021) · Molecules · doi:10.3390/molecules26196015 · Cited by 16
Peng, S., Roth, A. R., & Perry, B. L. (2021) · Social Neuroscience · doi:10.1080/17470919.2021.2001368 · Cited by 23
“Many studies have documented that weak ties promote access to novel ideas and knowledge about social activities, opportunities, stress, or health problems, and thus provide individuals with more diverse informational support (Barak et al., 2008; Granovetter, 1973; Wright & Miller, 2010).”
BackgroundPatient cognitive impairment associated with higher home health care delivery costs
Burgdorf, J. G., Sen, A. P., & Wolff, J. L. (2021) · Health Services Research · doi:10.1111/1475-6773.13928 · Cited by 14
Bailey-Taylor, M. J., Poupore, N. S., Roley, L. T., Goodwin, R. L., McPhail, B. T., & Nathaniel, T. I. (2022) · Brain Sciences · doi:10.3390/brainsci12020160 · Cited by 16
Nowrangi, M. A., Outen, J. D., Naaz, F., Chen, L., Bakker, A., Munro, C. A., Kamath, V. J., Rebok, G. W., & Rosenberg, P. B. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215148 · Cited by 16
“An estimated 6.2 million Americans have Alzheimer’s disease (AD) and this number is projected to grow to 13.8 million by mid-century [2].”
InfluentialAltered TIMP-3 Levels in the Cerebrospinal Fluid and Plasma of Patients with Alzheimer’s Disease
Park, J., Cho, S., Jo, C., Park, M. H., Han, C., Kim, E., Huh, G. Y., & Koh, Y. H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050827 · Cited by 15
Suchy‐Dicey, A. M., Oziel, K., Sawyer, C., Olufadi, Y., Ali, T., Fretts, A. M., Umans, J. G., Shibata, D. K., Longstreth, W. T., Rhoads, K., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201261 · Cited by 16
Knowledge of Alzheimer’s disease among the healthcare staff in a medical college hospital of India
Singh, J., Agrawal, A., Kumari, S., Tomar, S., Karn, A., & Singh, A. K. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_571_22 · Cited by 16
Wang, W., Zhang, S., Wang, Z., Luo, X., Luan, P., Hramov, A. E., Kurths, J., He, C., & Li, J. (2023) · IEEE Transactions on Cognitive and Developmental Systems · doi:10.1109/tcds.2023.3283406 · Cited by 16
Matošević, A., Opsenica, D., Spasić, M., Maraković, N., Zandona, A., Žunec, S., Bartolić, M., Kovarik, Z., & Bosak, A. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110620 · Cited by 16
Shaw, C. A., Williams, K. N., Perkhounkova, Y., Hein, M., & Coleman, C. (2020) · Clinical Gerontologist · doi:10.1080/07317115.2020.1729917 · Cited by 17
Kumari, A., Somvanshi, P., & Grover, A. (2020) · RSC Advances · doi:10.1039/d0ra00429d · Cited by 16
Portacolone, E., Covinsky, K. E., Johnson, J. K., & Halpern, J. (2020) · Qualitative Health Research · doi:10.1177/1049732320925796 · Cited by 15
Ethical and Regulatory Issues for Embedded Pragmatic Trials Involving People Living with Dementia
Largent, E. A., Hey, S. P., Harkins, K. A., Hoffman, A. K., Joffe, S., Lima, J. C., London, A. J., & Karlawish, J. H. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16620 · Cited by 16
Race and medicine in light of the new mechanistic philosophy of science
Kalewold, K. H. (2020) · Biology & Philosophy · doi:10.1007/s10539-020-09759-x · Cited by 17
Metadata
- Authors
- Alzheimer's Association
- Corresponding author
- Alzheimer's Association
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2019-03
- Volume
- 15
- Issue
- 3
- Pages
- 321-387
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W4211139529
- Cited by
- 2,461
- References
- 496
- Citations by year
- 2026: 108 · 2025: 214 · 2024: 245 · 2023: 310 · 2022: 357 · 2021: 558 · 2020: 544 · 2019: 120
- FWCI
- 316.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Alzheimer s & Dementia (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Keywords
- Alzheimer's disease, dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review